Table 2.
Effect of augmentation of ART dropout rates under “CD4<XX first” strategies on TPR, HIV incidence and ART coverage in 2034 in epidemic setting with low TPR (0.64) maintained.
| Strategy | ART dropout rates modification in 2027 |
|||
|---|---|---|---|---|
| Main analysis | Rates = 0.1 | Rates = 0.25 | Rates = 0.5 | |
| CD4<200 first | 0.62 | 0.63 | 0.64 | 0.64 |
| 4.2 | 5.0 | 7.3 | 9.5 | |
| 62.6% | 55.6% | 40.4% | 31.0% | |
| CD4<350 first | 0.62 | 0.63 | 0.64 | 0.64 |
| 3.9 | 4.9 | 7.5 | 9.9 | |
| 67.8% | 60.8% | 45.7% | 34.3% | |
| CD4<500 first | 0.62 | 0.63 | 0.64 | 0.64 |
| 3.7 | 5.0 | 7.7 | 10.3 | |
| 74.1% | 64.9% | 48.1% | 35.5% | |
| Universal first | 0.62 | 0.63 | 0.64 | 0.64 |
| 3.7 | 4.9 | 7.7 | 10.2 | |
| 74.6% | 65.3% | 48.3% | 35.6% | |
| Cell format (2034 metrics) | TPR value | |||
| HIV incidence | ||||
| ART coverage | ||||